Next Article in Journal
Lights and Shadows on the Sourcing of Silver Radioisotopes for Targeted Imaging and Therapy of Cancer: Production Routes and Separation Methods
Previous Article in Journal
Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 16
Issue 7
10.3390/ph16070928
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Pharmacological Effects of Grape Leaf Extract Reduce Eimeriosis-Induced Inflammation, Oxidative Status Change, and Goblet Cell Response in the Jejunum of Mice

by
Mutee Murshed
*,
Jameel Al-Tamimi
,
Hossam M. A. Aljawdah
and
Saleh Al-Quraishy
Department of Zoology, College of Science, King Saud University, P. O. Box 2455, Riyadh 11451, Saudi Arabia
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2023, 16(7), 928; https://doi.org/10.3390/ph16070928
Submission received: 25 May 2023 / Revised: 18 June 2023 / Accepted: 21 June 2023 / Published: 26 June 2023
(This article belongs to the Section Natural Products)
Browse Figures
Review Reports Versions Notes

Abstract

:
Coccidiosis is a parasitic infection threatening poultry products globally. Parasite resistance to drugs is one of the barriers to Eimeria control. Natural products are one of the sources of compounds that prevent parasite infections. The current study was, therefore, conducted to evaluate the effect of Vitis vinifera leaf extract on anti-inflammatory response, oxidative status, and goblet cell response against Eimeria papillate infection in mice. Methanol was used as a solvent for phytochemicals. The mice were divided into six groups: The first group was the control. The second group was uninfected and treated with 200 mg/kg of extract to test toxicity, and the third, fourth, fifth, and sixth groups of mice received 1 × 103 sporulated E. papillate oocysts. The third group received no treatment. The fourth and fifth groups were treated daily with 100 and 200 mg/kg of V. vinifera leaf extract, respectively, while the sixth group received 25 mg/kg of toltrazuril daily via gavage. On day 5 p.i., the animals were sacrificed, and jejunum samples were prepared for analyses of histological sections and oxidative stress. The phytochemical analysis using GC-MS of the extract showed the presence of 12 biologically active compounds. The most effective dose was 200 mg/kg, which significantly decreased the number of parasitic stages in the jejunal sections of the mice. The findings demonstrate that E. papillate infection in mice results in significant histopathological changes in the jejunum, including inflammation, epithelial vacuolation, villi loss, and a decrease in goblet cell density. When infected mice received treatment, the histological injury score within the infected jejunum tissue decreased by 63%, and the goblet cell quantity dramatically increased, approaching the control values. Finally, the extract ameliorated the changes in glutathione and malondialdehyde due to E. papillate infection. The extract was proven to have anti-inflammatory properties and reduce the number of oocysts. Overall, the findings show that V. vinifera leaf extract has significant anticoccidial effects in vivo.

1. Introduction

Eimeria is a widespread parasite that belongs to the Apicomplexa phylum and causes coccidiosis, which is one of the most frequent intestinal illnesses. Because they are the major agents in the transmission of avian coccidiosis, these protozoan parasites pose a concern to animals and poultry. They result in significant damage to the economy of the livestock industry [1,2]. Eimeria’s life cycle has two phases: one outside an infected animal and one within the intestines [3,4]. Eimeria rapidly proliferates in host cells and damages their digestive tracts [5]. Disease symptoms include diarrhea ranging from being watery to hemorrhagic from mucoid, along with feed malabsorption and decreased feed conversion efficiency, which causes weight loss and, in severe cases, leads to death [6]. Mice infected with Eimeria papillate have infections in their jejunum. This infection severely inflames the gut mucosa [7,8]. Mice are the mammalian model that is utilized most frequently in the fields of biomedical research all over the world [9]. Consequently, E. papillate is an excellent model for investigating avian coccidiosis [7].
Several drugs are used to eliminate Eimeria, such as drugs belonging to the pyridine group (Coyden), quinolone group (nequinate and decoquinate), ionophore group, halofuginone and quinazoline groups, thiamine antagonists (amprolium), and sulphonamide. But there are a number of issues, such as drug-resistant parasites and a deficiency in safe and effective vaccines, that contribute to the fact that the treatment of Eimeria with chemical medications does not succeed effectively and has a wide range of harmful effects [10]. For example, amprolium is a synthetic medication used in anti-coccidiosis therapy. Amprolium hydrochloride (1-[(4-amino-2-propyl-5-pyridinyl) methyl]-2-methyl pyridinium chloride monohydrochloride) is a small synthetic molecule that is a quaternized derivative of pyrimidine (C14H19ClN4). It belongs to a group of organic compounds called methyl pyridines, which have a pyridine ring with a methyl group in two places. This thiamine (vitamin B1) analog interferes with thiamine metabolism by blocking thiamine uptake and, thus, preventing the synthesis of carbohydrates in coccidiosis [11].
Although toltrazuril-based combination therapy against coccidiosis has shown exceptional responses, the limited medicinal options demand novel therapeutics. Furthermore, drug resistance is the cause in most cases, and new medications are proposed to overcome the resistance in addition to conventional therapeutics. The pathogenicity studies showed that the disease burden could be reduced by improving Eimeria diagnosis, strengthening prevention, parasitic-correct therapies, and adopting strategies to prevent drug resistance [12]. Despite the advances in treatment strategies, there are still challenges to discovering and developing new therapeutics to improve the quality of life and increase the survival rate [13]. One of the most critical resources for developing highly selective novel pharmaceuticals is using plants for medical purposes [14]. Recent research has found that natural plant sources can be an effective and offer a risk-free method for treating a variety of parasitic illnesses. Drug discovery based on natural products and secondary metabolites is considered an alternative approach for anti-coccidiosis therapy. Herbal medicines have advantages over modern treatments, including cost-effectiveness and affordability, thus encouraging herbal-based drug discovery. Several naturally occurring, semisynthetic, and synthetic anti-coccidiosis medications are on the market [15].
Vitis vinifera leaves is often regarded as one of the most significant plant species; it is a traditional therapeutic herb that contains phenolic compounds and is, therefore, a source of bioactive polyphenolic compounds, such as flavonoids and stilbenes [16]. In addition to polyphenolic components, grapes also contain beneficial fatty acids, including unsaturated fatty acids such as linoleic acid and oleic acid, which boost the nutritional value of grape leaf when it is used in food or as a dietary supplement [17]. Research has shown that grapes possess anti-inflammatory, antioxidant, cardio-protective, and anticancer properties. These benefits could be attributed to the presence of linoleic acid, tocopherol, carotenoids, and phytosterols, in addition to some polyphenolic compounds, such as proanthocyanidins, resveratrol, and quercetin [18]. Grapes contain a phytochemical called stilbene resveratrol, which is a powerful antioxidant. There is some evidence that it may help protect against cardiovascular illnesses [17]. In addition, research has indicated that an extract of whole grape berries may be more effective in bringing about health benefits, such as cytotoxic action against cancer cells of the lung, breast, and human liver than an extract of pure phytochemical molecules [19]. V. vinifera extracts obtained from various sources have demonstrated antifungal and antibacterial activities, lending credence to the plant’s historical application in various medicinal contexts, such as bacteria, viruses, parasites, and fungi. Wine, winery byproducts, and the bioactive components of these substances are all effective against human pathogens. They are employed as a treatment for pain relief due to the analgesic and anti-inflammatory qualities that they induce in mice infected with E. papillate [20,21].
Grape extract, in particular, has been shown to have various pharmacological and therapeutic effects, including antioxidative, anti-inflammatory, and antimicrobial properties [22]. In vivo testing revealed that Astragalus membranaceous possesses substantial anticoccidial activity against E. papillate infection [23]. Study results show that V. vinifera has a favorable, inhibitory, and protective effect against the sporulation of coccidian oocysts both in vitro and in vivo in mice [24]. The leaves of V. vinifera have been used to treat a wide range of illnesses, including hypertension, diarrhea, hemorrhage, varicose veins, and inflammatory turmoil, and to lower blood sugar levels [25]. Additionally, it has been demonstrated to be hepatoprotective against hepatic DNA damage brought on by acetaminophen [26].
The objective of this study is to evaluate the efficacy of an extract from the leaves of Vitis vinifera in vivo as a bioindicator of the response of goblet cells, in addition to the ameliorative effect on histopathology and oxidative stress caused by E. papillate infection in mice.

2. Results

2.1. The Phytochemical Analysis of VVE

Table 1 shows the most active chemical compounds of Vitis vinifera leaf extracts (VVE). The V. vinifera extracts contained 12 compounds; the main compound was oleic acid (211348260); other abundant compounds were linoleic acid (177748941), n-Hexadecanoic acid (53856562), 5-hydroxymethylfurfural (42615989), octadecanoic acid (20765095(5)), β-D-glucopyranose, 1,6-anhydrous (13056399), phytol (11334430), glycidyl oleate (9346792), 4H-pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl (6451576), 9,12-octadecadienoyl chloride, (Z, Z) (6451576), hexanedioic acid, and mono(2-ethylhexyl) ester (3630858) (Figure 1).

2.2. Effect of V. vinifera Extract on Fecal Oocyst Output on Day 5 p.i.

In the infected group, the level of oocyst production in the feces reached its highest point: approximately 93% oocysts per gram of feces. In the groups that were given the V. vinifera suspension, the production of oocysts was reduced by 34, 49, 64, and 66% with dosages of 100, 150, and 200 mg/kg of extract and 25 mL/kg of reference medicine, respectively (Figure 2); this represented a significant decrease. It was, therefore, quite clear that the dose of 200 milligrams per kilogram had the most significant potential to inhibit the production of fecal oocysts. As a result, for further research, we solely utilized the dose of 200 mL/kg of V. vinifera.

2.3. Histopathological Study of the Jejunum after Treatment

Hematoxylin and eosin staining was performed on a section of the mice’s jejunum to conduct additional research on the pathological changes brought on by the infection within the small intestine. Under a light microscope, the histopathological examination revealed considerable structural changes in the intestinal wall. Before receiving the extract treatment, gross pathological abnormalities could be seen in the small intestine in the infected group. These changes included edema, hyperemia, and petechial hemorrhages in the mesenteries.
These changes included bleeding in the intestinal villi, desquamation at the ends of the intestinal villi, and desquamation of mucosal epithelial cells, in addition to the development of parasitic stages (Figure 3). Villus height and crypt depth were significantly reduced in the infected group compared to the uninfected control mice. On the fifth day of treatment, the damage to the intestine caused by E. papillate was at its worst. As a direct consequence of this discovery, the tissue of the small intestine was harvested from the rats on the fifth day of therapy and used for subsequent molecular analysis.

2.4. Stages of Parasites

Portions of the jejunal villi that have been stained with hematoxylin and eosin are seen in Figure 1. In mice that had been infected with E. papillate and given various dosages of V. vinifera, the total number of intracellular E. papillate stages—including meronts, gamonts, and developing oocysts—was significantly reduced, particularly at a dose of 200 mg/kg of V. vinifera. This was especially obvious in the mice that had been given extracts to treat their condition. The mice that were given E. papillate became infected with the disease after receiving the organism. Epithelial cells in the jejunum of mice that had been experimentally infected with E. papillate oocysts formed distinct stages of the parasite. These mice were used to study the development of E. papillate. (Figure 4). Compared to the infected group, the treatment with V. vinifera resulted in a significant reduction of 64% in the number of parasitic stages counted per ten villous–crypt units (p ≤ 0.05).

2.5. The Effect of V. vinifera Leaf Extract on Goblet Cells in the Jejunum

Through the use of microscopic analysis of Alcian blue-stained jejunal sections, it was discovered that E. papillate infection led to a reduction in the number of goblet cells in the jejunum that was statistically significant (p ≤ 0.05) when compared to the non-infected group. On the other hand, when compared to the infected group, the jejunum of mice that had been given VVLE showed considerable increase in the number of goblet cells (Figure 5, Figure 6 and Figure 7).

2.6. Effect of VVLE on Oxidative Stress in the Jejunum

In the infected control group, infection with E. papillate resulted in a highly significant increase in malondialdehyde (p ≤ 0.001) and a substantial drop in TP and GSH (p ≤ 0.01, p ≤ 0.001), compared to the non-infected group. The treatment with a dose of 200 mg/kg of V. vinifera leaf extract, on the other hand, generated a significant drop in MD (p ≤ 0.001) and significant increases in GSH and TP (p ≤ 0.05 and p ≤ 0.001, respectively) (Figure 8, Figure 9 and Figure 10, respectively).

3. Discussion

It has been demonstrated in a number of studies that V. vinifera extract has the potential to be effective in treating a wide range of illnesses and conditions that affect the body [27,28]. It is well established that most anticoccidial treatments will produce a reduction in intracellular Eimeria stages and diminish their influence on the rate at which oocysts are shedding. The high concentrations of polyphenolic chemicals present in plant extracts may be responsible for the anticoccidial effects [8,29]. These chemicals have a significant antimicrobial impact because they interfere with the cell walls and membranes of microorganisms, changing the permeability of cell membranes to cations and water. This results in defective membrane functions and cellular component leakage, ultimately leading to cell death [30].
According to earlier studies, the carbohydrate content of intestinal epithelial cells and the severe structural abnormalities that result from the consumption of parasitic stages of Eimeria are to blame for the loss in cell membrane functions [31]. Because plant extracts contain bioactive compounds that contribute to improving the jejunal histological architecture after treatment, these benefits are realized. An infection with E. papillate is associated with a significant inflammatory response and oxidative damage to the jejunum of mice. The administration of V. vinifera to infected animals resulted in effective regulation of the oxidative damage that had been caused to the tissue of the mice’s jejunum [32,33]. According to the chronic toxicity studies by Thagfan et al. on mulberry extract, 200 mg/kg is safe without any specific toxicity or side effects [34]. This study tested three doses of V. vinifera (100, 150, and 200 mg/kg) as a natural target product against coccidia. It was also discovered that a grape leaf extract dosage could improve mice’s levels of phenols produced by their immune responses and have significant activity against cholinesterase and oxidative stress in a retrograde amnesia mouse model [28,35]. According to the findings of this research, a dose of 200 mg/kg had the highest anticoccidial efficacy out of all the doses that were examined. In addition, we demonstrated that the presence of V. vinifera disrupted the life cycle of E. papillate at every stage, as well as the oocyst sporulation process. This was evidenced by the considerable decrease in the number of parasitic developmental stages found in the jejunum as well as an increase in the number of fecal oocysts excreted. In addition, a dose-dependent pattern of efficient reduction in the amount of oocyst sporulation was discovered. The results of this research indicated that V. vinifera is an effective medication for the treatment of coccidiosis. The anticoccidial activity may be linked to the polyphenol content of the plant, which acts on protozoan development by interacting with cholesterol present on parasitic cell membranes. This results in the suppression and cessation of the life cycle of the parasite and ultimately parasitic death [36].
Bidens pilosa uses a similar mechanism to treat coccidiosis in hens by inhibiting oocyst sporulation and sporozoite invasion into cells [37]. Additionally, a suspension of V. vinifera appears to limit oocyst sporulation, which will ultimately lead to a reduction in the propagation of infection [37,38]. It is common knowledge that goblet cells can act as a dynamic defense system against harmful bacteria, viruses, and parasites by modifying the mucus contents and growing in both quantity and size [39]. It has been proven that stem cells that develop into goblet cells are restricted to the crypts of the digestive tract [40]. An analysis of histological sections of the jejunum conducted by Thagfan et al. revealed that the parasitic stages of E. papillate were most typically identified in the crypt region [41]. The significant decline in the number of goblet cells seen in the infected group might be explained by the fact that these cells were exposed to stem cells that had been parasitized and had lost their capacity to generate new cells on their own during the course of the infection [37].
The strong potential effect of V. vinifera leaf extract is due to the antioxidant and anti-inflammatory [42] activities of components of the plant extract. According to [43], a coccidial infection will produce an imbalance between the body’s innate antioxidant defenses and its generation of free radicals. The findings showed that E. papillate infection is associated with oxidative damage to the mice’s jejunum, which causes antioxidant enzymes to be depleted and GSH, TP, and MDA levels to be reduced. These oxidative parameters are crucial for shielding an animal’s body from free radical damage during Eimeria infection. Antioxidant enzymes use plant extracts’ active sites to detoxify the accumulation of reactive oxygen species that cause destructive changes in the jejunal epithelium [44,45]. V. vinifera significantly prevents the infection-induced loss of these markers and upregulates their activity, which is typically decreased during oxidative damage induced by infection. The synthesis of several carbonyl compounds, such as MDA, results from the oxidation of lipid peroxides [46].
In this work, anticoccidial medicines in the form of herbal extracts were employed to combat E. papillate infection. We conducted this study after finding that therapy with V. vinifera disrupts the growth process of this parasite, which, in turn, leads to a rise in the number of goblet cells arising from the harm done. Additionally, Forder and Thagfan previously reported that mulberry extract treatment has a significant effect and activity against Eimeria [41,47].
Based on the observations described above, we might conclude that V. vinifera possesses potent anticoccidial efficacy. This is supported by the observations showing a decline in the release of oocysts and sporulation, a reduction in the number of stages of parasite development found in the jejunum, and a recovery of normal goblet cell numbers.

4. Materials and Methods

4.1. Examination of experimental mice

The feces of the mice were analyzed six days before the beginning of the experiment using the flotation method and microscopic inspection of fallen oocysts in the feces, as described by Ryley et al. (1976). This was performed to guarantee that the animals did not have any coccidia [48].

4.2. Ethical Approval

This research was carried out according to the ethical guidelines for the use of animals established by the Kingdom of Saudi Arabia (Ethics Committee of King Saud University, approval number: KSU-SE-21-86).

4.3. Preparation of Vitis Vinifera Leaf Extracts

The V. vinifera leaf extracts were prepared using grape leaves from farms in Riyadh, Saudi Arabia. The botanical identity of the plant was confirmed by a taxonomist at the Department of Botany, King Saud University. The leaves were air-dried at 42 °C, ground into a powder, and then extracted with 80% methanol for 24 h at +4 °C [49]. The resulting extract was concentrated and dried in a rotating vacuum evaporator (Yamato RE300, Tokyo, Japan). The powder was dissolved in distilled water for the investigations of various experiments.

4.4. Phytochemical Analysis

Kanthal et al.’s procedure was used to conduct the phytochemical analysis of VVLE (2014). Gas chromatography–mass spectrometry (GC-MS) was performed using a 7000D Triple Quad GC-MS equipment (Agilent Technologies, Thermo Scientific, Austin, TX, USA). Thermo Scientific Trace GC Ultra and an ISQ single quadruple MS were used (Miami, CA, USA). The Agilent 7890A and 5975C inert XL EI/CI MSDs have a single quadrupole mass analyzer. A capillary HP-5MS UI (Ultra Inert) was used, with a length of 25 m, an inner diameter of 0.25 mm, a film thickness of 0.25 m, a stationary phase with 5% phenyl, and methylpolysiloxane (low polar). Helium was the carrier gas; the flow rate was 1 mL/min, the split ratio was 50:50, and the temperature was 250 °C. The GC-MS was run at 30 °C (5 min), at a rate of 5 Co/min, and then the temperature was increased to 250 °C (40 min). The temperature of the transfer line was 250 °C. The ionization energy in the MS environments was 70 eV. Full scan detection mode was used, with a mass range of 50–500 Da. The solvent delay was 1 min. Methanol was the sample solvent. The Wiley 9 database, responses, and libraries were used to identify the compounds. The components of the test substance were determined by name, molecular weight, molecular formula, and peak area.

4.5. Mice

The experiment was performed on mature male C57BL/6 mice that ranged in age from 10 to 13 weeks and weighed an average of 21 g per mouse. The animals were maintained in pathogen-free conditions in accordance with the procedures that were stated. The environment had a controlled temperature of 21 °C and a 50:50 light and darkness regimen, with standard diet and water provided ad libitum.

4.6. Sporulation of Oocysts

Professor Al-Quraishy obtained E. papillate oocysts in the parasitology laboratory, Zoology Department, in the College of Science at King Saud University in Saudi Arabia via passage through coccidian-free mice to stimulate the virulence of oocysts before they were used to infect the hosts, where they were maintained. Several mice were infected with an initial stock of sporulated oocysts. The mice had their feces collected to obtain unsporulated oocysts five days after infection, and new oocysts were sporulated so they could be used in the experiment. Fecal samples were collected using a modified version of the McMaster technique. For oocyst floatation, the fecal pellets of each mouse were suspended in a solution containing 2.5% potassium dichromate (w/v) in saturated sodium chloride (NaCl). The solution was then removed from the pellets by washing. After adjusting the total number of newly collected oocysts, one thousand sporulated oocysts suspended in one hundred microliters of water were orally gavaged into each mouse. This was performed to keep track of the oocyst-shedding numbers [50].

4.7. Treatment Design

The mice were distributed into seven groups, featuring five in each group. The first control group received 100 µL of sodium chloride (0.9% NaCl), and the second group received 200 mg/kg of V. vinifera leaf extract only, without infection, to determine toxicity. For the third, fourth, fifth, sixth, and seventh groups, the mice received 1 × 103 sporulated E. papillate oocysts. The third group did not receive any treatment. The fourth, fifth, and sixth groups were treated daily with 100, 150, and 200 mg/kg of V. vinifera leaf extract, respectively, while the seventh group received 25 mg/kg of toltrazuril every day for five days via gavage.

4.8. Sample Collection and Number of Oocysts in the Jejunum

On day 5, each mouse was sacrificed, and pieces of the jejunum were collected for histological examination and oxidative stress marker analysis; they were fixed in 10% neutral formalin buffer, dehydrated in ethanol, embedded in paraffin wax, and cut into 5 μm thick sections. Hematoxylin and eosin (H&E) staining was used on the sections (DRURY & WALLINGTON, 1980). The fixed tissues were then processed to assess parasitic developmental stages (meronts, gamonts, and developing oocysts in the groups that had been infected and treated with the plant extract or toltrazuril) based on the number of oocysts in every 10 well-oriented villous–crypt units (VCU) in all animals, utilizing an Olympus BX61 light microscopy (Tokyo, Japan).

4.9. Histopathological Examination

Excisions were made in the small intestine, and the samples were immediately washed in physiological saline and then fixed in phosphate-buffered formalin at a 70% concentration. After being set with formalin, the samples were encased in paraffin and then sectioned longitudinally at a thickness of 5 μm. Hematoxylin and eosin were used for staining after the segment of jejunum had been deparaffinized and dehydrated (Sigma). Using an Olympus BH2 microscope, observations of the microstructures of the small intestine were carried out (DP71, Olympus, Tokyo, Japan). Using an Olympus Image Analysis System, the height of the villus and the depth of the crypt of each of the ten well-oriented villi of each mouse were measured and recorded (Olympus 6.0, Tokyo, Japan).

4.10. Counting of Goblet Cells

The paraffin slices were rehydrated gradually in declining concentrations of ethanol and water before being deparaffinized with xylene. The sections were stained with Alcian blue (Sigma) to determine the number of goblet cells. Each animal’s jejunum was counted for the number of goblet cells in at least ten well-oriented villous–crypt units (VCUs). The average number of goblet cells per ten villi was calculated to represent the results [51].

4.11. Oxidative Stress

After weighing the jejunum from each of the different groups of mice, it was immediately homogenized in phosphate-buffered saline (PBS) in a buffer solution that had a pH of more than 7.4, and it was centrifuged at 5000× g for 15 min at a temperature of 4 degrees Celsius. After collecting the supernatant, 10 percent of the volume was utilized to determine the levels of oxidative stress markers. The levels of GSH and MDA in the jejunum were measured according to [52,53], respectively. In addition, total protein activity was measured in the mouse jejunum using the methodology described in [52,54].

4.12. Statistical Evaluation

For statistical comparisons between two groups, Student’s t-test was used. For statistical comparisons between more than two groups, an analysis of variance (ANOVA) test was used with post hoc Tukey’s test. The software program SPSS 12.0 was used to carry out the statistical analyses, and graphing was accomplished using version 5.0 of the program Graphpad Prism, Origin 2018 (Systat Software, Inc., Chicago, IL, USA). All findings were reported as mean accompanied by the standard error of the norm, with the threshold for statistical significance set at p ≤ 0.05.

5. Conclusions

Reducing parasites is essential for organisms’ health, which can contribute to sustainable production that keeps consumers healthy. Grape leaf extract has been shown to have anti-inflammatory characteristics. It is deduced that V. vinifera leaf extracts are strong against E. papillate-induced infection activity in light of the results mentioned above. This is shown by a decrease in the production of oocysts and sporulation, a reduction in parasitic developmental stages in the jejunum, and the recovery of normal goblet cell counts. There is significant improvement in the histological changes of the mice’s jejunum and antioxidant status. More research is required to gain an understanding of the mechanism by which grape leaf extract affects both the parasite and the host mice. To learn more about the plant’s pharmacological and therapeutic properties, more experimental studies and clinical research are required. This will help in the development of important therapeutic drugs based on the active phytochemical components of V. vinifera.

Author Contributions

Conceptualization, S.A.-Q. and M.M.; methodology, M.M; software, M.M.; validation, J.A.-T. and M.M.; formal analysis, J.A.-T.; investigation, S.A.-Q.; resources, H.M.A.A.; data curation, H.M.A.A. and J.A.-T.; writing—original draft preparation, M.M.; writing—review and editing, M.M. and J.A.-T.; visualization, M.M.; supervision, S.A.-Q.; project administration, S.A.-Q.; funding acquisition, S.A.-Q. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Acknowledgments

This work was supported by the Researchers Supporting Project (RSP2023R3) at King Saud University (Riyadh, Saudi Arabia).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Blake, D.P.; Tomley, F.M. Securing poultry production from the ever-present Eimeria challenge. Trends Parasitol. 2014, 30, 12–19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. López-Osorio, S.; Chaparro-Gutiérrez, J.J.; Gómez-Osorio, L.M. Overview of poultry Eimeria life cycle and host-parasite interactions. Front. Vet. Sci. 2020, 7, 384. [Google Scholar] [CrossRef] [PubMed]
  3. Lal, K.; Bromley, E.; Oakes, R.; Prieto, J.H.; Sanderson, S.J.; Kurian, D.; Hunt, L.; Yates III, J.R.; Wastling, J.M.; Sinden, R.E. Proteomic comparison of four Eimeria tenella life-cycle stages: Unsporulated oocyst, sporulated oocyst, sporozoite and second-generation merozoite. Proteomics 2009, 9, 4566–4576. [Google Scholar] [CrossRef] [Green Version]
  4. Mesa-Pineda, C.; Navarro-Ruíz, J.L.; López-Osorio, S.; Chaparro-Gutiérrez, J.J.; Gómez-Osorio, L.M. Chicken coccidiosis: From the parasite lifecycle to control of the disease. Front. Vet. Sci. 2021, 8, 787653. [Google Scholar] [CrossRef]
  5. Adhikari, P.; Kiess, A.; Adhikari, R.; Jha, R. An approach to alternative strategies to control avian coccidiosis and necrotic enteritis. J. Appl. Poult. Res. 2020, 29, 515–534. [Google Scholar] [CrossRef]
  6. Alnassan, A.; Kotsch, M.; Shehata, A.; Krüger, M.; Daugschies, A.; Bangoura, B. Necrotic enteritis in chickens: Development of a straightforward disease model system. Vet. Rec. 2014, 174, 555. [Google Scholar] [CrossRef]
  7. Abdel-Latif, M.; Abdel-Haleem, H.M.; Abdel-Baki, A.-A.S. Anticoccidial activities of chitosan on Eimeria papillata-infected mice. Parasitol. Res. 2016, 115, 2845–2852. [Google Scholar] [CrossRef] [PubMed]
  8. Qasem, M.A.; Dkhil, M.A.; Al-Shaebi, E.M.; Murshed, M.; Mares, M.; Al-Quraishy, S. Rumex nervosus leaf extracts enhance the regulation of goblet cells and the inflammatory response during infection of chickens with Eimeria tenella. J. King Saud Univ.-Sci. 2020, 32, 1818–1823. [Google Scholar] [CrossRef]
  9. Freires, I.A.; Sardi, J.d.C.O.; de Castro, R.D.; Rosalen, P.L. Alternative animal and non-animal models for drug discovery and development: Bonus or burden? Pharm. Res. 2017, 34, 681–686. [Google Scholar] [CrossRef]
  10. Shirley, M.W.; Smith, A.L.; Blake, D.P. Challenges in the successful control of the avian coccidia. Vaccine 2007, 25, 5540–5547. [Google Scholar] [CrossRef]
  11. Alturfan, A.A. Water-soluble vitamins. In A Guide to Vitamins and Their Effects on Diseases; Cambridge Scholars Publishing: Newcastle upon Tyne, UK, 2023; pp. 71–74. [Google Scholar]
  12. Hafez, H.M. Poultry coccidiosis: Prevention and control approaches. Arch. Fur Geflugelkd. 2008, 72, 2–7. [Google Scholar]
  13. Roessler, H.I.; Knoers, N.V.; van Haelst, M.M.; van Haaften, G. Drug repurposing for rare diseases. Trends Pharmacol. Sci. 2021, 42, 255–267. [Google Scholar] [CrossRef]
  14. Yuan, H.; Ma, Q.; Ye, L.; Piao, G. The traditional medicine and modern medicine from natural products. Molecules 2016, 21, 559. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Mohammadi, S.; Jafari, B.; Asgharian, P.; Martorell, M.; Sharifi-Rad, J. Medicinal plants used in the treatment of Malaria: A key emphasis to Artemisia, Cinchona, Cryptolepis, and Tabebuia genera. Phytother. Res. 2020, 34, 1556–1569. [Google Scholar] [CrossRef] [PubMed]
  16. Leifert, W.R.; Abeywardena, M.Y. Cardioprotective actions of grape polyphenols. Nutr. Res. 2008, 28, 729–737. [Google Scholar] [CrossRef]
  17. Sabra, A.; Netticadan, T.; Wijekoon, C. Grape bioactive molecules, and the potential health benefits in reducing the risk of heart diseases. Food Chem. X 2021, 12, 100149. [Google Scholar] [CrossRef]
  18. Garavaglia, J.; Markoski, M.M.; Oliveira, A.; Marcadenti, A. Grape seed oil compounds: Biological and chemical actions for health. Nutr. Metab. Insights 2016, 9, 59–64. [Google Scholar] [CrossRef] [Green Version]
  19. Balasubramani, S.P.; Rahman, M.A.; Basha, S.M. Synergistic action of stilbenes in Muscadine grape berry extract shows better cytotoxic potential against cancer cells than resveratrol alone. Biomedicines 2019, 7, 96. [Google Scholar] [CrossRef] [Green Version]
  20. Mai, K.; Sharman, P.A.; Walker, R.A.; Katrib, M.; Souza, D.D.; McConville, M.J.; Wallach, M.G.; Belli, S.I.; Ferguson, D.J.; Smith, N.C. Oocyst wall formation and composition in coccidian parasites. Mem. Do Inst. Oswaldo Cruz 2009, 104, 281–289. [Google Scholar] [CrossRef] [Green Version]
  21. Friedman, M. Antibacterial, antiviral, and antifungal properties of wines and winery byproducts in relation to their flavonoid content. J. Agric. Food Chem. 2014, 62, 6025–6042. [Google Scholar] [CrossRef] [PubMed]
  22. Nassiri-Asl, M.; Hosseinzadeh, H. Review of the pharmacological effects of Vitis vinifera (Grape) and its bioactive compounds. Phytother. Res. 2009, 23, 1197–1204. [Google Scholar]
  23. Abdel-Tawab, H.; Abdel-Baki, A.; El-Mallah, A.; Al-Quraishy, S.; Abdel-Haleem, H. In vivo and in vitro anticoccidial efficacy of Astragalus membranaceus against Eimeria papillata infection. J. King Saud Univ.-Sci. 2020, 32, 2269–2275. [Google Scholar] [CrossRef]
  24. Murshed, M.; Al-Quraishy, S.; Alghamdi, J.; Aljawdah, H.; Mares, M.M. The Anticoccidial Effect of Alcoholic Vitis vinifera Leaf Extracts on Eimeria papillate Oocysts Isolated in Mice In Vitro and In Vivo. Vet. Sci. 2023, 10, 97. [Google Scholar] [CrossRef]
  25. Walker, J.B. Evaluation of the ability of seven herbal resources to answer questions about herbal products asked in drug information centers. Pharmacother. J. Hum. Pharmacol. Drug Ther. 2002, 22, 1611–1615. [Google Scholar] [CrossRef] [PubMed]
  26. Ercisli, S.; Orhan, E. Chemical composition of white (Morus alba), red (Morus rubra) and black (Morus nigra) mulberry fruits. Food Chem. 2007, 103, 1380–1384. [Google Scholar] [CrossRef]
  27. Leifer, A.; Barberio, D.M. Direct ingestion method for enhancing production and bioavailability of resveratrol and other phytoalexins in Vitis vinifera. Med. Hypotheses 2016, 88, 1–5. [Google Scholar] [CrossRef]
  28. Simonetti, G.; Brasili, E.; Pasqua, G. Antifungal activity of phenolic and polyphenolic compounds from different matrices of Vitis vinifera L. against human pathogens. Molecules 2020, 25, 3748. [Google Scholar] [CrossRef]
  29. Oke, E.; Adeyi, O.; Okolo, B.; Adeyi, J.; Ayanyemi, J.; Osoh, K.; Adegoke, T. Phenolic compound extraction from Nigerian Azadirachta indica leaves: Response surface and neuro-fuzzy modelling performance evaluation with Cuckoo search multi-objective optimization. Results Eng. 2020, 8, 100160. [Google Scholar]
  30. Huang, Q.; Liu, X.; Zhao, G.; Hu, T.; Wang, Y. Potential and challenges of tannins as an alternative to in-feed antibiotics for farm animal production. Anim. Nutr. 2018, 4, 137–150. [Google Scholar] [CrossRef]
  31. Qaid, M.M.; Al-Mufarrej, S.I.; Azzam, M.M.; Al-Garadi, M.A. Anticoccidial effectivity of a traditional medicinal plant, Cinnamomum verum, in broiler chickens infected with Eimeria tenella. Poult. Sci. 2021, 100, 100902. [Google Scholar] [CrossRef] [PubMed]
  32. Badgujar, S.B.; Patel, V.V.; Bandivdekar, A.H.; Mahajan, R.T. Traditional uses, phytochemistry and pharmacology of Ficus carica: A review. Pharm. Biol. 2014, 52, 1487–1503. [Google Scholar] [PubMed] [Green Version]
  33. Murshed, M.; Al-Quraishy, S.; Qasem, M.A. In vitro: Anti-coccidia activity of Calotropis procera leaf extract on Eimeria papillata oocysts sporulation and sporozoite. Open Chem. 2022, 20, 1057–1064. [Google Scholar] [CrossRef]
  34. Thagfan, F.A.; Al-Megrin, W.A.; Al-Quraishy, S.; Dkhil, M.A.M. Mulberry extract as an ecofriendly anticoccidial agent: In vitro and in vivo application. Rev. Bras. De Parasitol. Veterinária 2020, 29, e009820. [Google Scholar] [CrossRef] [PubMed]
  35. Qiu, C.; Cheng, Y. Effect of Astragalus membranaceus polysaccharide on the serum cytokine levels and spermatogenesis of mice. Int. J. Biol. Macromol. 2019, 140, 771–774. [Google Scholar] [CrossRef] [PubMed]
  36. Zaman, M.A.; Iqbal, Z.; Abbas, R.Z.; Khan, M.N. Anticoccidial activity of herbal complex in broiler chickens challenged with Eimeria tenella. Parasitology 2012, 139, 237–243. [Google Scholar] [CrossRef]
  37. Yang, W.-C.; Yang, C.-Y.; Liang, Y.-C.; Yang, C.-W.; Li, W.-Q.; Chung, C.-Y.; Yang, M.-T.; Kuo, T.-F.; Lin, C.-F.; Liang, C.-L. Anti-coccidial properties and mechanisms of an edible herb, Bidens pilosa, and its active compounds for coccidiosis. Sci. Rep. 2019, 9, 2896. [Google Scholar] [CrossRef] [Green Version]
  38. Fatemi, A.; Razavi, S.M.; Asasi, K.; Torabi Goudarzi, M. Effects of Artemisia annua extracts on sporulation of Eimeria oocysts. Parasitol. Res. 2015, 114, 1207–1211. [Google Scholar] [CrossRef]
  39. Khan, W. Physiological changes in the gastrointestinal tract and host protective immunity: Learning from the mouse-Trichinella spiralis model. Parasitology 2008, 135, 671–682. [Google Scholar] [CrossRef] [Green Version]
  40. Chen, C.-L.; Yu, X.; James, I.O.; Zhang, H.-y.; Yang, J.; Radulescu, A.; Zhou, Y.; Besner, G.E. Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis. Lab. Investig. 2012, 92, 331–344. [Google Scholar] [CrossRef] [Green Version]
  41. Thagfan, F.A.; Dkhil, M.A.; Al-Quraishy, S. In vivo anticoccidial activity of Salvadora persica root extracts. Pak. J. Zool 2017, 49, 53–57. [Google Scholar] [CrossRef]
  42. Abdel-Moneim, A.-M.E.; El-Saadony, M.T.; Shehata, A.M.; Saad, A.M.; Aldhumri, S.A.; Ouda, S.M.; Mesalam, N.M. Antioxidant and antimicrobial activities of Spirulina platensis extracts and biogenic selenium nanoparticles against selected pathogenic bacteria and fungi. Saudi J. Biol. Sci. 2022, 29, 1197–1209. [Google Scholar] [CrossRef]
  43. Georgieva, N.; Koinarski, V.; Gadjeva, V. Antioxidant status during the course of Eimeria tenella infection in broiler chickens. Vet. J. 2006, 172, 488–492. [Google Scholar] [CrossRef] [PubMed]
  44. Surai, P.F.; Kochish, I.I.; Fisinin, V.I.; Kidd, M.T. Antioxidant defence systems and oxidative stress in poultry biology: An update. Antioxidants 2019, 8, 235. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Elmahallawy, E.K.; Fehaid, A.; El-Shewehy, D.M.; Ramez, A.M.; Alkhaldi, A.A.; Mady, R.; Nasr, N.E.; Arafat, N.; Hassanen, E.A.; Alsharif, K.F. S-methylcysteine ameliorates the intestinal damage induced by Eimeria tenella infection via targeting oxidative stress and inflammatory modulators. Front. Vet. Sci. 2022, 1482. [Google Scholar] [CrossRef] [PubMed]
  46. Hassan, R.; Soliman, E.; Hamad, R.; El-Borady, O.; Ali, A.; Helal, M. Selenium and nano-selenium ameliorations in two breeds of broiler chickens exposed to heat stress. South Afr. J. Anim. Sci. 2020, 50, 215–232. [Google Scholar] [CrossRef]
  47. Forder, R.; Nattrass, G.; Geier, M.; Hughes, R.; Hynd, P. Quantitative analyses of genes associated with mucin synthesis of broiler chickens with induced necrotic enteritis. Poult. Sci. 2012, 91, 1335–1341. [Google Scholar] [CrossRef]
  48. Ryley, J.; Meade, R.; Hazelhurst, J.; Robinson, T.E. Methods in coccidiosis research: Separation of oocysts from faeces. Parasitology 1976, 73, 311–326. [Google Scholar] [CrossRef]
  49. Kanthal, L.K.; Dey, A.; Satyavathi, K.; Bhojaraju, P. GC-MS analysis of bio-active compounds in methanolic extract of Lactuca runcinata DC. Pharmacogn. Res. 2014, 6, 58. [Google Scholar] [CrossRef] [Green Version]
  50. Schito, M.L.; Barta, J.R.; Chobotar, B. Comparison of four murine Eimeria species in immunocompetent and immunodeficient mice. J. Parasitol. 1996, 82, 255–262. [Google Scholar] [CrossRef]
  51. Allen, A.; Hutton, D.; Leonard, A.; Pearson, J.; Sellers, L. The role of mucus in the protection of the gastroduodenal mucosa. Scand. J. Gastroenterol. 1986, 21, 71–78. [Google Scholar] [CrossRef] [PubMed]
  52. Jollow, D.; Mitchell, J.; Zampaglione, N.; Gillette, J. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974, 11, 151–169. [Google Scholar] [CrossRef] [PubMed]
  53. Buege, J.A.; Aust, S.D. Microsomal lipid peroxidation. In Methods in Enzymology; Elsevier: Amsterdam, The Netherlands, 1978; Volume 52, pp. 302–310. [Google Scholar]
  54. Buege, J.; Aust, S. Microsomal lipid peroxidation methods. Enzymol 1978, 52, 302–310. [Google Scholar]
Pharmaceuticals 16 00928 g001 550
Figure 1. Infrared spectroscopy of V. vinifera leaf extracts.
Figure 1. Infrared spectroscopy of V. vinifera leaf extracts.
Pharmaceuticals 16 00928 g001
Pharmaceuticals 16 00928 g002 550
Figure 2. Effect of V. vinifera leaf extracts: oocyst production decrease in parasitic stages in mice with E. papillate infection in the jejunum. All values are displayed as mean ± SE. * Significant deviation from the control (p ≤ 0.05).
Figure 2. Effect of V. vinifera leaf extracts: oocyst production decrease in parasitic stages in mice with E. papillate infection in the jejunum. All values are displayed as mean ± SE. * Significant deviation from the control (p ≤ 0.05).
Pharmaceuticals 16 00928 g002
Pharmaceuticals 16 00928 g003 550
Figure 3. Histological changes in the jejunal sections of mice due to infection with Eimeria papillate sporulated oocysts that have been stained with hematoxylin and eosin on day 5 p.i.: (A) control (-VVLE); (B) infected (-VVLE) indicated by arrows; (C) non-infected (+VVLE); (D) 100% (infected + VVLE); (E) 200% (infected + VVLE); and (F) infected + 25 mg/kg of toltrazuril. Scale bar = 50 μm.
Figure 3. Histological changes in the jejunal sections of mice due to infection with Eimeria papillate sporulated oocysts that have been stained with hematoxylin and eosin on day 5 p.i.: (A) control (-VVLE); (B) infected (-VVLE) indicated by arrows; (C) non-infected (+VVLE); (D) 100% (infected + VVLE); (E) 200% (infected + VVLE); and (F) infected + 25 mg/kg of toltrazuril. Scale bar = 50 μm.
Pharmaceuticals 16 00928 g003
Pharmaceuticals 16 00928 g004 550
Figure 4. Oocyst production patterns of mice treated with varying dosages of V. vinifera leaf extracts on day 5 post-treatment and infection with E. papillate (all values reported as mean ± SE). * Significant deviation from the control group (p ≤ 0.05).
Figure 4. Oocyst production patterns of mice treated with varying dosages of V. vinifera leaf extracts on day 5 post-treatment and infection with E. papillate (all values reported as mean ± SE). * Significant deviation from the control group (p ≤ 0.05).
Pharmaceuticals 16 00928 g004
Pharmaceuticals 16 00928 g005 550
Figure 5. On day 5 post-inoculation, E. papillate infection was found in the jejunum: (A,B) distinct developmental phases. Meront (ME), macrogamont (MA), and microgamont (MI) shown in (A). Macrogamont (MA), microgamont (MI), and developing oocyst (DO) shown in (B). Hematoxylin and eosin, also known as H&E, were used to stain the sections.
Figure 5. On day 5 post-inoculation, E. papillate infection was found in the jejunum: (A,B) distinct developmental phases. Meront (ME), macrogamont (MA), and microgamont (MI) shown in (A). Macrogamont (MA), microgamont (MI), and developing oocyst (DO) shown in (B). Hematoxylin and eosin, also known as H&E, were used to stain the sections.
Pharmaceuticals 16 00928 g005
Pharmaceuticals 16 00928 g006 550
Figure 6. The influence of extracts from the leaves of V. vinifera on the number of goblet cells that are present in the jejunum of mice that have an infection caused by E. papillate. (A) represents the control group; (B) represents the infected group that has developmental stages; (C) represents the non-infected V. vinifera leaf extract group; (D) represents the treated group that received 100 mg/kg of V. vinifera extract; (E) represents the treated group that received 200 mg/kg and has fewer goblet cells; and (F) represents the infected group that underwent therapy with toltrazuril. Alcian blue was used to stain the sections. Scale bar = 50 µm.
Figure 6. The influence of extracts from the leaves of V. vinifera on the number of goblet cells that are present in the jejunum of mice that have an infection caused by E. papillate. (A) represents the control group; (B) represents the infected group that has developmental stages; (C) represents the non-infected V. vinifera leaf extract group; (D) represents the treated group that received 100 mg/kg of V. vinifera extract; (E) represents the treated group that received 200 mg/kg and has fewer goblet cells; and (F) represents the infected group that underwent therapy with toltrazuril. Alcian blue was used to stain the sections. Scale bar = 50 µm.
Pharmaceuticals 16 00928 g006
Pharmaceuticals 16 00928 g007 550
Figure 7. Effect of V. vinifera leaf extracts: reduction in goblet cell population in E. papillate-infected mouse jejunum. All values are expressed as mean ± SE. Significant deviation from the control group (p ≤ 0.05) is denoted with *.
Figure 7. Effect of V. vinifera leaf extracts: reduction in goblet cell population in E. papillate-infected mouse jejunum. All values are expressed as mean ± SE. Significant deviation from the control group (p ≤ 0.05) is denoted with *.
Pharmaceuticals 16 00928 g007
Pharmaceuticals 16 00928 g008 550
Figure 8. The effect of V. vinifera leaf extracts on the levels of oxidative stress markers (GSH) in the jejunum of mice infected with E. papillate. All values are shown as mean ± SE. CN: control; Inf: infected; VVLE: Vitis vinifera leaf extract. * Significant difference when compared to the control group (p < 0.01). # Significant difference when compared to the control group (p < 0.05).
Figure 8. The effect of V. vinifera leaf extracts on the levels of oxidative stress markers (GSH) in the jejunum of mice infected with E. papillate. All values are shown as mean ± SE. CN: control; Inf: infected; VVLE: Vitis vinifera leaf extract. * Significant difference when compared to the control group (p < 0.01). # Significant difference when compared to the control group (p < 0.05).
Pharmaceuticals 16 00928 g008
Pharmaceuticals 16 00928 g009 550
Figure 9. The effect of VVLE on the levels of oxidative stress markers (MDA) in the jejunum of mice infected with E. papillate. All values are shown as mean ± SE. CN: control; Inf: infected; VVLE: Vitis vinifera leaf extract. * Significant difference when compared to the control group (p < 0.05). # Significant difference when compared to the control group (p < 0.05).
Figure 9. The effect of VVLE on the levels of oxidative stress markers (MDA) in the jejunum of mice infected with E. papillate. All values are shown as mean ± SE. CN: control; Inf: infected; VVLE: Vitis vinifera leaf extract. * Significant difference when compared to the control group (p < 0.05). # Significant difference when compared to the control group (p < 0.05).
Pharmaceuticals 16 00928 g009
Pharmaceuticals 16 00928 g010 550
Figure 10. The effect of V. vinifera leaf extracts on the levels of oxidative stress markers (TP) in the jejunum of mice infected with E. papillate. All values are shown as mean ± SE. CN: control; Inf: infected; VVLE: Vitis vinifera leaf extract. * Significant difference when compared to the control group (p < 0.05). # Significant difference when compared to the control group (p < 0.05).
Figure 10. The effect of V. vinifera leaf extracts on the levels of oxidative stress markers (TP) in the jejunum of mice infected with E. papillate. All values are shown as mean ± SE. CN: control; Inf: infected; VVLE: Vitis vinifera leaf extract. * Significant difference when compared to the control group (p < 0.05). # Significant difference when compared to the control group (p < 0.05).
Pharmaceuticals 16 00928 g010
Table
Table 1. Phytochemical compounds identified through GC-MS in Vitis vinifera leaf extracts.
Table 1. Phytochemical compounds identified through GC-MS in Vitis vinifera leaf extracts.
Retention Time (min)PhytochemicalsChemical GroupMolecular
Weight		FormulaPeak Area%
7.464H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl-Flavonoid144C6H8O41.16
8.845-HydroxymethylfurfuralFuranic aldehyde126C6H6O37.66
12.50β-D-Glucopyranose, 1,6-anhydro-Pyranose162C6H10O52.35
17.89n-Hexadecanoic acidFatty acid256C16H32O29.68
19.39PhytolDiterpene296C20H40O2.04
19.64Linoleic acid Polyunsaturated fatty acids (PUFA)280C18H32O231.93
19.69Oleic acidMonounsaturated fatty acids (MUFA)282C18H34O237.97
19.86Octadecanoic acidSaturated fatty acids284C18H36O23.73
21.96Hexanedioic acid, mono(2-ethylhexyl) esterAdipic acid ester258C14H26O40.65
22.61Glycidyl oleateGlycidyl ester338C21H38O31.68
24.349,12-Octadecadienoyl chloride, (Z, Z)-Fatty acyl chlorides298C18H31ClO1.15
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Murshed, M.; Al-Tamimi, J.; Aljawdah, H.M.A.; Al-Quraishy, S. Pharmacological Effects of Grape Leaf Extract Reduce Eimeriosis-Induced Inflammation, Oxidative Status Change, and Goblet Cell Response in the Jejunum of Mice. Pharmaceuticals 2023, 16, 928. https://doi.org/10.3390/ph16070928

AMA Style

Murshed M, Al-Tamimi J, Aljawdah HMA, Al-Quraishy S. Pharmacological Effects of Grape Leaf Extract Reduce Eimeriosis-Induced Inflammation, Oxidative Status Change, and Goblet Cell Response in the Jejunum of Mice. Pharmaceuticals. 2023; 16(7):928. https://doi.org/10.3390/ph16070928

Chicago/Turabian Style

Murshed, Mutee, Jameel Al-Tamimi, Hossam M. A. Aljawdah, and Saleh Al-Quraishy. 2023. "Pharmacological Effects of Grape Leaf Extract Reduce Eimeriosis-Induced Inflammation, Oxidative Status Change, and Goblet Cell Response in the Jejunum of Mice" Pharmaceuticals 16, no. 7: 928. https://doi.org/10.3390/ph16070928

APA Style

Murshed, M., Al-Tamimi, J., Aljawdah, H. M. A., & Al-Quraishy, S. (2023). Pharmacological Effects of Grape Leaf Extract Reduce Eimeriosis-Induced Inflammation, Oxidative Status Change, and Goblet Cell Response in the Jejunum of Mice. Pharmaceuticals, 16(7), 928. https://doi.org/10.3390/ph16070928

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop